ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,852.42
      -0.09%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Clene Inc (CLNN) Quote

      Clene Inc

      Clene Inc (CLNN)

      NASDAQ
      4.49
      0.03
      (0.67%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      4.49
      0.00
      (0.00%)
      After Hours: 6:53PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      4.49
      Bid
      4.40
      Ask
      4.50
      Volume
      22,470
      4.4001 Day's Range 4.6716
      4.23 52 Week Range 15.80
      Market Cap
      28.833M
      Previous Close
      4.46
      Open
      4.42
      Last Trade
      2
      @
      4.49
      Last Trade Time
      Financial Volume
      $ 100,617
      VWAP
      4.4778
      Average Volume (3m)
      513,821
      Shares Outstanding
      6,421,686
      Dividend Yield
      -
      PE Ratio
      -0.57
      Earnings Per Share (EPS)
      -7.71
      Revenue
      654k
      Net Profit
      -49.5M

      About Clene Inc

      Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.clene.com
      Headquarters
      Dover, Delaware, USA
      Founded
      1970
      Clene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLNN. The last closing price for Clene was $4.46. Over the last year, Clene shares have traded in a share price range of $ 4.23 to $ 15.80.

      Clene currently has 6,421,686 shares outstanding. The market capitalization of Clene is $28.64 million. Clene has a price to earnings ratio (PE ratio) of -0.57.

      CLNN Latest News

      More News

      Form 8-K - Current report

      4 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      July 11 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      July 09 2024
      Edgar (US Regulatory)

      IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington

      LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) --  via IBN – IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...

      May 01 2024
      GlobeNewswire Inc.

      IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington

      LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...

      March 19 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      February 29 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      February 22 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

      February 14 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.35-7.231404958684.844.924.23376394.46711234CS
      4-2.632-36.95591126097.1227.3964.233483435.74819672CS
      12-4.19-48.27188940098.689.24.235138217.12702952CS
      26-6.11-57.64150943410.6114.237265837.60225986CS
      52-10.51-70.06666666671515.84.236908898.16549984CS
      156-155.51-97.19375160196.84.2354992335.20798822CS
      260-192.91-97.7254305978197.4356.44.2351455955.28953915CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		259.77k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      CLNN Discussion

      View Posts
      Termite7 Termite7 2 months ago
      Lower please.....thanks!!!
      👍️0
      Awl416 Awl416 3 months ago
      Pop
      👍️0
      Monksdream Monksdream 5 months ago
      CLNN 10Q due March 8
      👍️0
      Monksdream Monksdream 7 months ago
      CLNN new 52 week low
      👎️ 1 🤡 1 🩳 1
      scotsand scotsand 7 months ago
      Running now. Join the fun.
      👍️0
      Monksdream Monksdream 9 months ago
      CLNN new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      CLNN new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      CLNN new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      CLNN new 52 week low
      👍️0
      Louman Louman 11 months ago
      7 analyst ratings still 100% buy. PT $4-$10.
      👍️0
      Louman Louman 1 year ago
      $3.4 million in inside buys between 6-20 and 6-27. Price target $5. 7 analyst ratings 100% buy
      👍️0
      bwrbad bwrbad 1 year ago
      THIS IS ONE ISSUE DO NOT MISS
      👍️0
      JUST 10-11-12 JUST 10-11-12 1 year ago
      i.ll take 12 bucks per share
      👍️0
      CapGainsman CapGainsman 1 year ago
      EF Hutton initiates coverage today on CLNN with a $13 price target. And HC Wainwright has reiterated a $15 price target twice in recent days. And CLNN has reported positive trial results in recent weeks. Other than there appear to be a bunch of pesky shorters involved, this seems like a gift down here. Also, CLNN will be presenting in the upcoming Roth's 35th annual healthcare conference.
      👍️0
      81vette 81vette 1 year ago
      12mms stacked,bid/demand growing,13k@1.21,could pop any min now
      👍️0
      81vette 81vette 1 year ago
      Over 3m shares short,some covering has to happen
      👍️0
      81vette 81vette 1 year ago
      Day1 of higher high/higher low,gotta love nabbing the very beginning of bulls being turned loose,market is manipulated the worst in 20 years,mms/banks have gotten ridiculously greedy,can’t beat em/join um is my motto
      👍️0
      81vette 81vette 1 year ago
      My Scanner telling me buy now,bulls back to loading for run again
      👍️0
      skichic skichic 1 year ago
      Oppenheimer has a buy rating of Overweight for CLNN and a price target of $20.00!
      👍️0
      skichic skichic 1 year ago
      Strange how CLNN traded today. Fantastic news, huge insider buy and the shorts controlled. Absolutely crazy. I added to my stash big time!
      👍️0
      81vette 81vette 1 year ago
      Bills have to get paid,maybe done in after mkt for continued this year long up trend,
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      ALL DAY FADER= ZZZZZZZZZ
      👍️0
      81vette 81vette 1 year ago
      todays news>https://capedge.com/news/benzinga/30873738/clene-reports-new-data?fromCompany=1822791
      👍️0
      81vette 81vette 1 year ago
      zero borrow>no shares available to short(float locked up),insider buys up 400%,recient news coverage blowing up,283Xs ave vol will get attention today
      👍️0
      81vette 81vette 1 year ago
      #1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
      👍️0
      81vette 81vette 1 year ago
      #1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
      👍️0
      81vette 81vette 1 year ago
      Shares Outstanding 63.51M,Shares Float 27.20M,Institutional Ownership 6.00%,Insider Ownership 8.80%,Short Float 6.74%
      👍️0
      harry crumb harry crumb 1 year ago
      Any reason this is active other than form 4’s filed? Their lead science candidate failed
      👍️0
      tw0122 tw0122 1 year ago
      At least you got the board opened flipped it once already when it went under $2 $1.95 to $2.17. Maybe will try one more time on a pullback..
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      https://clene.com/pipeline/
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      https://finviz.com/quote.ashx?t=CLNN&ty=c&ta=1&p=d
      👍️0

      Your Recent History

      NASDAQ
      CLNN
      Clene
      BIT
      F13709
      Vontobel Financial Produ...
      EU
      ASNO
      ASN Beleggingsfondsen Ai...
      EU
      MELE
      Melexis
      Delayed Upgrade Clock